SRL
PCVX icon

Scientech Research LLC’s Vaxcyte PCVX Stock Holding History

Scientech Research LLC’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-17,406
Closed -$566K – 778
2025
Q2 		$566K Buy
+17,406
New +$571K 0.14% 297
2025
Q1 		– Sell
-15,273
Closed -$1.25M – 751
2024
Q4 		$1.25M Buy
15,273
+2,385
+19% +$237K 0.35% 60
2024
Q3 		$1.47M Buy
+12,888
New +$1.16M 0.29% 102
2024
Q2 		– Sell
-7,289
Closed -$498K – 704
2024
Q1 		$498K Buy
7,289
+4,034
+124% +$279K 0.26% 165
2023
Q4 		$204K Buy
+3,255
New +$169K 0.2% 248

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Scientech Research LLC's PCVX Position: Q3 2025 in Review

Scientech Research LLC sold out of Vaxcyte (PCVX) in Q3 2025, closing a stake of 17,406 shares — an estimated $566K sold.

Scientech Research LLC first reported a position in PCVX in Q4 2023 and held it in 5 quarters. The position peaked at $1.47M in Q3 2024. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • Scientech Research LLC reported no remaining Vaxcyte position as of Q3 2025 after selling out during the quarter.
  • Scientech Research LLC sold 17,406 Vaxcyte shares in Q3 2025, an estimated $566K.
  • Scientech Research LLC first reported a position in Vaxcyte in Q4 2023 and held it in 5 quarters.
  • Scientech Research LLC's Vaxcyte position peaked at $1.47M in Q3 2024.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Scientech Research LLC's 13F filing for Q3 2025, filed 14 Nov 2025.